CTAS

Value Q3, 24Q4, 24Q1, 25Q2, 25 TTM Total revenue 2.61 B2.67 B2.72 B2.8 B 10.79 B Gross profit 2.61 B2.67 B1.37 B1.41 B 8.06 B Operating expenses 752.69 M896.34 M790.9 M798.07 M 3.24 B Selling/general/admin expenses 709.49 M728.54 M748.7 M756.77 M 2.94 B Research & development ———— — Operating income 609.85 M597.45 M617.86 M655.71 M 2.48 B Non-Operating Income, Total 1.35 M2.02 M2.21 M866 K 6.45 M Interest expense, net of interest capitalized 24.76 M24.06 M24.16 M28.08 M 101.06 M Non-Operating Income, excl. Interest Expenses -23.41 M-22.04 M-21.95 M-27.21 M -94.61 M Unusual income/expense ———— — Pretax income 586.44 M575.41 M595.91 M628.5 M 2.39 B Equity in earnings ———— — Taxes 122.94 M127.16 M104.77 M133.16 M 488.03 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 463.5 M448.26 M491.14 M495.34 M 1.9 B Discontinued operations ———— — Net income 463.5 M448.26 M491.14 M495.34 M 1.9 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 461.87 M446.77 M489.49 M493.74 M 1.89 B Basic earnings per share (Basic EPS) 1.141.111.211.23 4.69 Diluted earnings per share (Diluted EPS) 1.131.081.21.21 4.62 Average basic shares outstanding 403.77 M403.53 M403.29 M401.48 M 1.61 B Diluted shares outstanding 410.31 M410.29 M409.29 M406.43 M 1.64 B EBITDA ——701.6 M741.91 M — EBIT ——575.66 M614.41 M — Cost of revenue ——1.35 B1.39 B — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 130.09 M121.89 M125.94 M127.5 M 505.42 M